Gary Margolis is the Chief Executive Officer of Notogen Inc., a pre-clinical biotechnology company developing a biologic regenerative therapy for degenerative disc disease. 

Prior to joining Notogen, Gary was the Managing Director, General Counsel and Chief Compliance Officer at DRI Capital Inc., one of the world’s largest, healthcare-focused private equity funds.  During his tenure with DRI Capital, Gary conducted the legal and intellectual property due diligence, led the negotiations on, and played a leadership role in, more than a hundred pharmaceutical royalty acquisition opportunities. 

Prior to joining DRI Capital, Gary was a legal associate with Dewey Ballantine LLP in London, UK, and Simpson Thacher & Bartlett LLP in New York, and began his legal career with Osler, Hoskin & Harcourt LLP in Toronto. Gary practiced primarily in the areas of mergers and acquisitions and securities law. 

Gary earned both his Bachelor of Sciences degree in Human Biology and his Juris Doctor legal degree from the University of Toronto.   Gary lives in Toronto with his wife and two daughters.